Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
EJNMMI Physics|December 23, 2025
Morphological versus spherical cellular geometry models: impact on dose-response of CA20948 cells to <sup>177</sup>Lu- and <sup>161</sup>Tb-labeled DOTA-TATE and DOTA-LM3Kaat Spoormans, Melissa Crabbé, Lara Struelens, et al.
Scientific Reports|September 11, 2019
Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging studyMelissa Crabbé, Nina Dirkx, Cindy Casteels, et al.
Theranostics|October 21, 2024
Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancerMelissa Crabbé, Tomas Opsomer, Koen Vermeulen, et al.
Pharmaceutics|October 27, 2022
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)Kaat Spoormans, Melissa Crabbé, Lara Struelens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 29, 2024
The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for <sup>161</sup>Tb Compared with <sup>177</sup>Lu with a Higher Dose Response for [<sup>161</sup>Tb]Tb-DOTA-LM3 Than for [<sup>161</sup>Tb]Tb-DOTATATEKaat Spoormans, Lara Struelens, Koen Vermeulen, et al.
Neurobiology of Aging|October 23, 2017
Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesiaMelissa Crabbé, Anke Van der Perren, Akila Weerasekera, et al.
EJNMMI Radiopharmacy and Chemistry|July 15, 2024
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastomaAnthony Waked, Melissa Crabbé, Virginie Neirinckx, et al.
Experimental Neurology|May 29, 2019
Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathyMelissa Crabbé, Anke Van der Perren, Savannah Kounelis, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|October 20, 2021
Review of extremity dosimetry in nuclear medicineRobert Kollaard, Alessandra Zorz, Jérémie Dabin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2019
Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's diseaseJenny Ceccarini, Cindy Casteels, Rawaha Ahmad, et al.
Pageof 2